Comparing Methods of Recall for Cancer Screening in Primary Care: a Pragmatic Clinical Trial

Not Applicable

Completed

• Conditions: Early Detection of Cancer; Cancer; Socioeconomic Status
• Interventions: Behavioral: Letter; Behavioral: Phone call

• Registration Number: NCT02457143
• Lead Sponsor: Unity Health Toronto

Brief Summary

This randomized trial aims to understand how effective a reminder letter is compared to a reminder phone call in improving breast, cervical and colorectal cancer screening rates and reducing screening disparities.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2015-05-27
• Study First Submitted QC: 2015-05-28
• Study First Posted: 2015-05-29
• Study Start: 2015-07
• Primary Completion: 2016-07
• Study Completion: 2016-07
• Status Verified: 2016-10
• Last Update Submitted: 2016-10-14
• Last Update Posted: 2016-10-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 5270

Inclusion Criteria

• The trial will include patients who are rostered to the family practice as of March 31, 2015, are eligible and overdue for cervical, breast and/or colorectal cancer screening and are verified by their primary care physician as needing recall.

Exclusion Criteria

• Patients will be excluded if their primary care physician noted they should not be recalled for screening or if the patient does not have both an address and a phone number on file.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Letter	Letter	Patients will receive a reminder letter signed by their family physician which indicates which cancer screening tests they are overdue for and encourages them to book an appointment for screening.
Phone call	Phone call	Patients will receive a phone call from a member of the practice staff. The call will inform them about which cancer screening tests they are overdue for and will encourage them to book an appointment for screening.

Primary Outcome Measures

Name	Time	Method
The proportion of patients in each arm who go on to receive at least one screening test for which they are due	6 months
The proportion of patients in each arm who are due for breast, cervical and colorectal cancer screening who go on to receive those respective screening tests (female patients may be represented in the outcome calculation of more than one cancer screening	6 months

Trial Locations

Locations (1)

St. Michael's Hospital Academic Family Health Team; 🇨🇦 Toronto, Ontario, Canada